Cinclus Pharma Holding AB Company Description

Cinclus Pharma Holding AB (publ), a clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases.

Its lead product is linaprazan glurate for the treatment of gastroesophageal reflux disease (GERD) and peptic ulcer bacteria Helicobacter pylori (H.

pylori). The company was founded in 2014 and is based in Stockholm, Sweden.

Cinclus Pharma Holding AB (publ)

Country	Sweden
Founded	2014
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	13
CEO	Christer Ahlberg

Contact Details

Address: Kungsbron 1 Stockholm, 11122 Sweden
Phone	46 8 13 33 10
Website	cincluspharma.com

Stock Details

Ticker Symbol	CINPHA
Exchange	Nasdaq Stockholm
Fiscal Year	January - December
Reporting Currency	SEK
SIC Code	2834

Key Executives

Name	Position
Christer Ahlberg	Chief Executive Officer and President
Dr. Lennart Hansson Ph.D.	Co-founder and Chairman of the Board
Peter Unge	Co-founder and Director
Kjell Andersson	Co-Founder and Chief Scientific Officer
Maria Engstrom	Chief Financial Officer
Gosta Hiller	Chief Operating Officer
Bengt Erlandsson	Head of CMC and IP
Kajsa Larsson	Chief Medical Officer
Malin Filler	Head of Regulatory Affairs